Literature DB >> 7926823

In vivo functional relationships among terminal proteins of Bacillus subtilis phi 29-related phages.

A Bravo1, J M Hermoso, M Salas.   

Abstract

Gene 3 of the Bacillus subtilis phage phi 29 encodes the terminal protein (TP), which acts as a primer in the initiation of viral DNA replication. We have developed an in vivo functional assay for the phi 29 TP based on the ability of TP-producing B. subtilis non-suppressor (su-) cells to support DNA replication of a phi 29 sus3 mutant phage. This trans-complementation assay has been used to study in vivo functional relationships between the TP of phi 29 and related phages. Our results demonstrate that phi 29 TP functionally substitutes the TP of phage PZA, whereas replication of phage Nf DNA cannot take place in vivo using the phi 29 TP as a primer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926823     DOI: 10.1016/0378-1119(94)90242-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Homologies and divergences in the transcription regulatory system of two related Bacillus subtilis phages.

Authors:  Laura Pérez-Lago; Margarita Salas; Ana Camacho
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

2.  A genetic approach to the identification of functional amino acids in protein p6 of Bacillus subtilis phage phi 29.

Authors:  A Bravo; J M Hermoso; M Salas
Journal:  Mol Gen Genet       Date:  1994-12-01

3.  Involvement of phage phi29 DNA polymerase and terminal protein subdomains in conferring specificity during initiation of protein-primed DNA replication.

Authors:  Patricia Pérez-Arnaiz; Elisa Longás; Laurentino Villar; José M Lázaro; Margarita Salas; Miguel de Vega
Journal:  Nucleic Acids Res       Date:  2007-10-02       Impact factor: 16.971

Review 4.  DNA-Binding Proteins Essential for Protein-Primed Bacteriophage Φ29 DNA Replication.

Authors:  Margarita Salas; Isabel Holguera; Modesto Redrejo-Rodríguez; Miguel de Vega
Journal:  Front Mol Biosci       Date:  2016-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.